The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma.

Saved in:
Bibliographic Details
Title: The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma.
Authors: Boone MA; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Taslim C; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Crow JC; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Selich-Anderson J; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Byrum AK; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Showpnil IA; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, USA., Sunkel BD; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Wang M; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA., Stanton BZ; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University, Columbus, OH, USA., Theisen ER; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University, Columbus, OH, USA., Lessnick SL; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA. stephen.lessnick@nationwidechildrens.org.; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. stephen.lessnick@nationwidechildrens.org.; Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, USA. stephen.lessnick@nationwidechildrens.org.; Department of Pediatrics, The Ohio State University, Columbus, OH, USA. stephen.lessnick@nationwidechildrens.org.
Source: Oncogene [Oncogene] 2021 Jul; Vol. 40 (29), pp. 4759-4769. Date of Electronic Publication: 2021 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene
Database: MEDLINE Ultimate
Description
ISSN:1476-5594
DOI:10.1038/s41388-021-01876-5